These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15450348)

  • 1. Neuroimmunophilins: a novel drug therapy for the reversal of neurodegenerative disease?
    Poulter MO; Payne KB; Steiner JP
    Neuroscience; 2004; 128(1):1-6. PubMed ID: 15450348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunophilin dysfunction and neuropathology.
    Park HJ; Rosado JA; Redondo PC; Cho YS
    Curr Med Chem; 2011; 18(35):5398-407. PubMed ID: 22087832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of FK506 (tacrolimus) to alleviate apomorphine-induced circling in rat Parkinson model in spite of some cytoprotective effects in SH-SY5Y dopaminergic cells.
    Manáková S; Singh A; Kääriäinen T; Taari H; Kulkarni SK; Männistö PT
    Brain Res; 2005 Mar; 1038(1):83-91. PubMed ID: 15748876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular pathways leading to neuronal dysfunction and degeneration.
    Kazantsev AG
    Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetaminophen attenuates dopamine neuron degeneration in animal models of Parkinson's disease.
    Locke CJ; Fox SA; Caldwell GA; Caldwell KA
    Neurosci Lett; 2008 Jul; 439(2):129-33. PubMed ID: 18514411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress, age-related neurodegeneration, and the potential for neurotrophic treatment.
    Williams LR
    Cerebrovasc Brain Metab Rev; 1995; 7(1):55-73. PubMed ID: 7742172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPI-1485 (Guilford).
    Marshall VL; Grosset DG
    Curr Opin Investig Drugs; 2004 Jan; 5(1):107-12. PubMed ID: 14983983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy.
    Weinreb O; Amit T; Bar-Am O; Youdim MB
    Ann N Y Acad Sci; 2007 Dec; 1122():155-68. PubMed ID: 18077571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases.
    Waldmeier P; Bozyczko-Coyne D; Williams M; Vaught JL
    Biochem Pharmacol; 2006 Nov; 72(10):1197-206. PubMed ID: 16901468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection.
    Ganel R; Ho T; Maragakis NJ; Jackson M; Steiner JP; Rothstein JD
    Neurobiol Dis; 2006 Mar; 21(3):556-67. PubMed ID: 16274998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death.
    Fernandez-Gomez FJ; Gomez-Lazaro M; Pastor D; Calvo S; Aguirre N; Galindo MF; Jordán J
    Neurobiol Dis; 2005 Nov; 20(2):384-91. PubMed ID: 16242643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
    Liu B; Dluzen DE
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling and synthesis of non-cyclic derivatives of GPI-1046 as potential FKBP ligands with neurotrophic properties.
    Zhao L; Liu H; Wang L; Li S
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4385-90. PubMed ID: 16753298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flavopiridol: an antitumor drug with potential application in the treatment of neurodegenerative diseases.
    Pallàs M; Verdaguer E; Jordà EG; Jiménez A; Canudas AM; Camins A
    Med Hypotheses; 2005; 64(1):120-3. PubMed ID: 15533627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.
    Zhao L; Huang W; Liu H; Wang L; Zhong W; Xiao J; Hu Y; Li S
    J Med Chem; 2006 Jul; 49(14):4059-71. PubMed ID: 16821768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FKBP family proteins: immunophilins with versatile biological functions.
    Kang CB; Hong Y; Dhe-Paganon S; Yoon HS
    Neurosignals; 2008; 16(4):318-25. PubMed ID: 18635947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
    Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
    Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.